Greg Garland - Amgen Insider

AMGN -- USA Stock  

USD 185.01  1.06  0.58%

Independent Director

Mr. Greg C. Garland is an Independent Director of Amgen Inc. Mr. Garland is the Chairman President and Chief Executive Officer of Phillips 66 an energy manufacturing and logistics company with midstream chemical refining and marketing and specialties businesses created through the repositioning of ConocoPhillips having held this position since April 2012. Mr. Garland chairs the Executive Committee of Phillips 66. Prior to Phillips 66 Mr. Garland served as Senior Vice President Exploration and Production Americas of ConocoPhillips from 2010 to April 2012. He was President and Chief Executive Officer of Chevron Phillips Chemical Company from 2008 to 2010 and Senior Vice President Planning and Specialty Chemicals from 2000 to 2008. Mr. Garland served in various positions at Phillips Petroleum Company from 1980 to 2000. Mr. Garland is a member of the Engineering Advisory Board for Texas AM University.
Age: 56  Director Since 2013      

Greg Garland Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.84 % which means that it generated profit of $8.84 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 9.59 % meaning that it created $9.59 on every $100 dollars invested by stockholders.
The company currently holds 35.54 B in liabilities with Debt to Equity (D/E) ratio of 227.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen has Current Ratio of 3.8 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Shane CookeEndo International plc
Adriane BrownAllergan plc
John StrattonAbbott Laboratories
William YoungVertex Pharmaceuticals Incorpor
Katherine BaickerEli Lilly and Company
Yuchun LeeVertex Pharmaceuticals Incorpor
Patrick OSullivanAllergan plc
Karen VousdenBristol Myers Squibb Company
Ellen MarramEli Lilly and Company
Todd SisitskyEndo International plc
David AltshulerVertex Pharmaceuticals Incorpor
Sharad MansukaniEndo International plc
Gregory HinckleyBio Rad Laboratories
Louis DrapeauBio Rad Laboratories
Carol DavidsonAllergan plc
Kneeland YoungbloodMallinckrodt Public Limited Com
William SpenglerEndo International plc
Peter McDonnellAllergan plc
Togo WestBristol Myers Squibb Company
Jamere JacksonEli Lilly and Company
Robert BertoliniBristol Myers Squibb Company

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ. It employs 20800 people.Amgen (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Amgen Leadership Team

Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance Indicators

Did you try this?

Run Insider Screener Now

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Insider Screener

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Amgen and IQVIA Holdings. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.